Overview

Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis (ARTROCELL)

Status:
Active, not recruiting

Trial end date:
2025-12-01

Target enrollment:

Participant gender:

Summary

Phase III, multicenter, randomized, open-label, multicenter clinical trial comparing treatment with allogeneic mesenchymal cells versus autologous mesenchymal cells and versus active control with hyaluronic acid in patients with knee osteoarthritis.

Phase:

Phase 3

Details

Lead Sponsor:

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

Collaborators:

Hospital Universitari de Bellvitge
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Instituto de Investigación Biomédica de Salamanca
Spanish Clinical Research Network - SCReN

Treatments:

Hyaluronic Acid